Hepatic CCN2 expression was significantly induced in NASH patients with F3–F4 fibrosis and was positively correlated with hepatic Col1A1, Col1A2, Col3A1, or αSMA expression. The gene discussed is COL3A1; the disease is metabolic dysfunction-associated steatohepatitis.